- FREE SHIPPING ON ORDERS OVER $200
Size: 10mg
Contents: CJC-1295 without DAC (5mg) + Ipamorelin (5mg)
Form: Lyophilized Powder
Purity: ≥99%
Quantity: 10 Vials
CJC-1295 without DAC 5mg + IPA 5mg is a synthetic peptide research combination containing CJC-1295 without DAC and Ipamorelin (IPA). Researchers investigate this combination in controlled laboratory environments to study growth hormone-releasing pathways, peptide-receptor interactions, cellular signaling, and endocrine-related mechanisms.
The combination has attracted scientific interest because both peptides are studied in relation to growth hormone signaling pathways. Laboratory researchers examine their individual molecular characteristics and combined behavior to better understand receptor activity, cellular communication, and peptide-mediated signaling mechanisms.
CJC-1295 without DAC is a growth hormone-releasing hormone (GHRH) analog investigated for its interaction with GHRH-related signaling pathways. Ipamorelin is a synthetic peptide studied for its interaction with growth hormone secretagogue receptors.
Combining these two research peptides provides an experimental model for investigating different components of growth hormone-related signaling. Researchers continue to examine their molecular interactions and cellular responses under controlled laboratory conditions.
Compound Type: Synthetic Peptide Research Combination
Research Focus: Growth hormone signaling and peptide-receptor research
Primary Function: GHRH and growth hormone secretagogue pathway research
Research involving CJC-1295 without DAC focuses on its relationship with GHRH receptor signaling, while Ipamorelin is investigated for its interaction with growth hormone secretagogue receptor pathways. Scientists study these mechanisms to better understand peptide-mediated signaling and endocrine communication.
Laboratory investigations may examine receptor interactions, downstream cellular signaling, and the relationship between different growth hormone-related pathways. Further research is required to fully characterize the combined behavior of these compounds.
CJC-1295 without DAC + IPA is commonly investigated in laboratory studies focused on:
Its combined research profile provides scientists with an experimental model for studying multiple peptide-mediated signaling pathways associated with growth hormone biology.
CJC-1295 without DAC and Ipamorelin have each been studied for their relationships with growth hormone-related signaling pathways. Researchers continue to examine their molecular characteristics, receptor interactions, and cellular signaling behavior.
Studying the two peptides together may provide additional opportunities to investigate interactions between different signaling mechanisms in controlled experimental models. Ongoing research may contribute to a broader understanding of peptide-receptor biology and endocrine signaling pathways.
Product Name: CJC-1295 without DAC 5mg + IPA 5mg
Content: CJC-1295 without DAC 5mg + Ipamorelin (IPA) 5mg
Total Content: 10mg per vial
Quantity: 10 Vials
Form: Lyophilized Powder
Purity: ≥99%
Store in a cool, dry place away from direct sunlight, heat, and moisture to help maintain product stability and research-grade quality. Refrigeration may be appropriate according to established laboratory storage protocols. After reconstitution, follow applicable laboratory procedures and stability requirements for proper storage and handling.
Proper storage under controlled laboratory conditions can help preserve the integrity of the peptide combination and support consistent experimental research. Always handle and store the product according to appropriate laboratory protocols and keep it in a secure environment intended for qualified research professionals.
CJC-1295 without DAC 5mg + IPA 5mg is intended strictly for research and laboratory use only. It is not approved for human consumption, medical use, or therapeutic applications. This product is not intended to diagnose, treat, cure, or prevent any disease or condition. All handling and experimentation must be performed by qualified professionals in accordance with applicable laws, regulations, and institutional laboratory protocols.
